A case of metastatic malignant melanoma treated with toripalimab
The incidence of malignant melanoma is low,the mortality is high,and the survival time is short.In the early stage,surgery is the main treatment;in the late stage,chemical drugs are mostly used,but the effective rate is not high.Immunotherapy has achieved advanced and breakthrough development in the treatment of a variety of malignant tumors,and has also been proved to prolong the survival time of malignant melanoma patients in clinical practice.This article is to share a case of metastatic malignant melanoma treated with toripalimab who has achieved good efficacy in the First Affiliated Hospital of Jinan University.
万方数据
维普
